Patient wants to study hepatocarcinoma" Grow and store with tumour " 's prevention and health care

Patient wants to study hepatocarcinoma" Grow and store with tumour " 's prevention and health care
It is a surgical founder of liver and gall of our country that academician, the second army medical university eastern liver and gall surgical director Wu Meng of PLA man of Chinese Academy of Sciences at the venerable age of 85 exceed, once served as 12 times " The international hepatitis hepatocarcinoma meeting " Waited for the president or common President of the important academic meeting, and won State Pre-eminent Science and Technology Award in 2005. At the tenth China clinical oncological conference and CSCO academic annual meeting in 2007, the new view about treating hepatocarcinoma that ultra academician Wu Meng puts forward attracts people's attention - --He proposes patient wants to learn hepatocarcinoma " Grow and store with tumour " .
Academician Wu MengChao says, the therapeutic main trend of hepatocarcinoma is the complex treatment relying mainly on early surgery at present. The reason why no longer depend on the operation simply, because people realize gradually hepatocarcinoma is a kind of whole body disease, we often only paid close attention to the liver in the past, but the fact proved, the effecting a radical cure excision can not prevent recuring, it is obvious hepatocarcinoma is not a question of the single organ. In addition, the recurring rate of postoperative hepatocarcinoma is very high in later period, the recuring rate is up to 50% in 5. Unless in view of being the above-mentioned situation, it treat now last one of views news hepatocarcinoma,namely"and tumour be deposited to be grown " . Some hepatocarcinoma patients often died of complication because of excessively treating in the past, do not die of tumour. " and tumour is grown and stored " This new view emphasizes it is rational through science much mode, individual treat, to improve patient's tolerance, lengthen the life, lighten the agony.
Meng Wu exceed still until of our country the intersection of liver and transfer operation use excessive present situation got criticism out of at present. Wu MengChao thinks, that is suitable for accepting liver transplantation should be a particular early hepatocarcinoma patient, and for not shifting and the cancer bolt will be the prerequisite. Some doctors make liver transfer operation to later period hepatocarcinoma too now, often make the patient " lose both the person and money " finally . Must admit, the present medical level is still very limited, the liver supports the body to be very precious at the same time, also need long time limit to inhibit the immunity after liver transplantation, so liver transplantation which launches hepatocarcinoma must be very cautious, hold this view extensively too in the world.
As the emeritus President of this CSCO conference, Wu Meng exceeds and places the great expectations on future development of CSCO. He says, the run-up of CSCO conference will promote the standardization of the medical market of tumour effectively, help to study alternately discipline, promote the development of the anticancer work of our country together.
|